Key result
In patients with stable angina, the highest quartile of the TG/HDL-C ratio independently predicted the composite of all-cause mortality and non-fatal myocardial infarction (HR 2.85).
Why the study?
It was unknown whether high triglycerides and low HDL-C levels, expressed by an increased TG/HDL-C ratio, predict CAD outcomes in patients with stable angina.
Does an increased TG/HDL-C ratio predict all-cause mortality and non-fatal myocardial infarction in patients with stable angina?
Observational (n=355)
Yes
Does an increased TG/HDL-C ratio predict all-cause mortality and non-fatal myocardial infarction in patients with stable angina?
Hazard Ratio: 2.85 (95% CI 1.3–6.26)
p-value: p=< 0.01
In patients with stable angina, an increased TG/HDL-C ratio independently predicts all-cause mortality and non-fatal MI, highlighting the residual risk associated with atherogenic dyslipidemia despite LDL-C reduction.
May support TG/HDL-C ratio for risk stratification in stable angina; leaves open validation in larger prospective studies.
We assessed whether high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) levels, expressed by an increased TG/HDL-C ratio, predict coronary atherosclerotic disease (CAD) outcomes in patients with stable angina. We studied 355 patients (60 ± 9 years, 211 males) with stable angina who underwent coronary computed tomography angiography (CTA), were managed clinically and followed for 4.5 ± 0.9 years. The primary composite outcome was all-cause mortality and non-fatal myocardial infarction. At baseline, the proportion of males, patients with metabolic syndrome, diabetes and obstructive CAD increased across TG/HDL-C ratio quartiles, together with markers of insulin resistance, hepatic and adipose tissue dysfunction and myocardial damage, with no difference in total cholesterol or LDL-C. At follow-up, the global CTA risk score (HR 1.06, 95% confidence interval (CI) 1.03-1.09, P = 0.001) and the IV quartile of the TG/HDL-C ratio (HR 2.85, 95% CI 1.30-6.26, P < 0.01) were the only independent predictors of the primary outcome. The TG/HDL-C ratio and the CTA risk score progressed over time despite increased use of lipid-lowering drugs and reduction in LDL-C. In patients with stable angina, high TG and low HDL-C levels are associated with CAD related outcomes independently of LDL-C and treatments.Trial registration. EVINCI study: ClinicalTrials.gov NCT00979199, registered September 17, 2009; SMARTool study: ClinicalTrials.gov NCT04448691, registered June 26, 2020.
No takes yet. Share an insight, caveat, or question.
Caselli et al. (2021) conducted an observational in Stable angina (n=355). High TG/HDL-C ratio (IV quartile) vs. Lower TG/HDL-C ratio (I-III quartiles) was evaluated on Composite of all-cause mortality and non-fatal myocardial infarction (HR 2.85, 95% CI 1.30-6.26, p=< 0.01). In patients with stable angina, the highest quartile of the TG/HDL-C ratio independently predicted the composite of all-cause mortality and non-fatal myocardial infarction (HR 2.85).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: